Board Meetings for NATCOPHARM

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
NATCOPHARMNatco Pharma Limited29 May 2026Financial ResultsTo consider and approve the Audited financial results for the period ended March 31, 2026
NATCOPHARMNatco Pharma Limited29 May 2026Board Meeting IntimationNATCO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2026 .
NATCOPHARMNatco Pharma Limited24 Mar 2026Other business mattersTo consider Scheme of arrangement (demerger)
NATCOPHARMNatco Pharma Limited24 Mar 2026Board Meeting IntimationNATCO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 24-Mar-2026 to consider Scheme of arrangement.
NATCOPHARMNatco Pharma Limited12 Feb 2026Board Meeting IntimationNATCO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Feb-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Dividend.
NATCOPHARMNatco Pharma Limited12 Feb 2026Financial Results/DividendTo consider and approve the financial results for the period ended December 31, 2025 and Interim dividend, if any for FY 2025-26
NATCOPHARMNatco Pharma Limited14 Nov 2025Board Meeting IntimationNATCO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2025 and Dividend.
NATCOPHARMNatco Pharma Limited14 Nov 2025Financial Results/DividendTo consider and approve the financial results for the period ended September 30, 2025 and 2nd Interim dividend for the Financial Year ending 2025-26
NATCOPHARMNatco Pharma Limited12 Aug 2025Board Meeting IntimationNATCO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Aug-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2025 and Dividend.
NATCOPHARMNatco Pharma Limited12 Aug 2025Financial Results/DividendTo consider and approve the financial results for the period ended Jun 30, 2025 and interim dividend for the FY 25-26
NATCOPHARMNatco Pharma Limited28 May 2025Board Meeting IntimationNATCO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 28-May-2025 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2025 .
NATCOPHARMNatco Pharma Limited28 May 2025Financial ResultsTo consider and approve the Audited financial results for the period ended March 31, 2025
NATCOPHARMNatco Pharma Limited12 Feb 2025Financial Results/DividendTo consider and approve the financial results for the period ended December 31, 2024 and 3rd Interim dividend, if any
NATCOPHARMNatco Pharma Limited12 Feb 2025Board Meeting IntimationNATCO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Feb-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2024 and Dividend.
NATCOPHARMNatco Pharma Limited12 Nov 2024Board Meeting IntimationNATCO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2024 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2024 and Dividend.
Showing page 1 of 8 (109 total items)
Next